Evidence from clinical studies has shown increased mutation frequency or reduced CFTR expression in men with congenital bilateral absence of vas deferens or sperm abnormalities, such as azoospermia teratozoospermia and oligoasthenospermia. This evidence concerns the gene CFTR and Abnormal sperm morphology.